Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China.

Autor: Shenyu, Wang1 (AUTHOR) sywang@cdc.zj.cn, Xiaoqian, Duan1,2 (AUTHOR) duanxiaoqian@sinovac.com, Bo, Chen1,3 (AUTHOR) 362085291@qq.com, Xuan, Deng1 (AUTHOR) xdeng@cdc.zj.cn, Zeng, Wang2 (AUTHOR) wangzeng@sinovac.com, Hangjie, Zhang1 (AUTHOR) hjzhang@cdc.zj.cn, Qianhui, Zheng3 (AUTHOR) zzliang@cdc.zj.cn, Zhenzhen, Liang1 (AUTHOR) zzliang@cdc.zj.cn, Chuanfu, Yan3 (AUTHOR), Juan, Yang4 (AUTHOR), Gang, Zeng1,2 (AUTHOR) zengg@sinovac.com, Huakun, Lv1 (AUTHOR) hklv@cdc.zj.cn
Zdroj: Vaccine. Aug2022, Vol. 40 Issue 36, p5356-5365. 10p.
Databáze: Academic Search Ultimate
Externí odkaz: